AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu significantly improved progression-free survival in metastatic breast patients with low and ultralow HER2 expression levels who had received at least one line of systemic treatment.
Ono Pharmaceutical said Monday it will pay $2.4 billion to acquire Deciphera Pharmaceuticals for cancer drugs that could generate peak annual sales of more than $1 billion.
IRIS offers immersive insights reports and live dashboards designed to help the healthcare industry and other stakeholders anticipate and identify transformative market events, and how best to strategically navigate the fast-moving environment.
2023 was definitely a busy year for many agencies as the world continued to move on from the pandemic. Despite economic headwinds, several of the agencies featured in this issue reported growth and an increase in the number of their clients and accounts held. The other commonality noted in these profiles was an unhesitating attitude towards the adoption of generative and analytical AI tools for themselves and their clients, leading to new opportunities.
“Ken embodies the essence of leadership, not just through his actions but through his unwavering commitment to do better … to be better. Ken embodies a culture of continuous learning and development, encouraging each member of our team to reach their full potential.”
Sarah Hansen is associate director, US Patient Marketing Metabolics, Alexion. She was nominated by Snow Companies.